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INTRODUCTION
The killing of endothelial cells either by activated neu-
trophils or by addition of H2O2 has been extensively
studied. Several different, important themes related to
the mechanism of cell killing have recently emerged. 1)
Depending on their origin, the susceptibility of endothe-
hal cells to oxidant-mediated killing by neutrophils var-
ies. 2) In some respects, the killing of endothelial cells
by activated neutrophils involves a participation of en-
dothelial cells in their own destruction. 3) The killing of
endothelial cells by products of neutrophils does not oc-
cur by a single, commonly accepted biochemical event.
4) Endothelial cell killing appears to be mediated by
synergistic interaction of oxygen products and proteases
from leukocytes. 5) Finally, endothelial cells can be
modified by contact with cytokines such that their sus-
ceptibility to killing by neutrophils is greatly enhanced.
VARIATION IN SUSCEPTIBILITY OF
ENDOTHELIAL CELLS TO
NEUTROPHIL-MEDIATED DAMAGE
There are several bodies of evidence suggesting that
endothelial cell damage by phorbol ester-activated neu-
trophils varies with regard to the mechanism of injury.
Human umbilical vein endothelial cells and rat pulmo-
nary artery endothelial cells have been reported to be
susceptible to damage by neutrophils in a manner that is
related to the generation of toxic oxygen products from
neutrophils [1-4]. The damage can be largely abrogated
by catalase and by the iron chelator deferroxamine but
not by superoxide dismutase (SOD), suggesting that an
iron-dependent product of H2O2, perhaps the hydroxyl
radical (HO), is the damaging oxygen product. In addi-
tion, if neutrophils from patients with chronic granulo-
matous disease (COD) are employed, little or no endo-
thelial cell injury occurs, consistent with the conclusion
that injury is due to a toxic oxygen product of the respi-
ratory burst. In contrast, microvascular endothelial cells
obtained from human omentum are injured by contact
with phorbol ester-activated neutrophils obtained from
normal human volunteers or from patients with COD,
and catalase is nonprotective [5,6]. The protective ef-
fects of chiormethyl ketone inhibitors, which inactivate
the catalytic site in elastase, have been taken to suggest
that this type of endothelial cell injury is related to the
effect of a granule-released product, such as elastase.
Collectively, these data indicate that, within the same
species, endothelial cells may be injured by neutrophils
via two independent mechanisms, one being oxygen rad-
ical-mediated and the other being independent of this
pathway. In addition to these pathways of cytotoxic in-
jury, endothelial cell monolayers may be disrupted by
neutrophil products (presumably proteolytic enzymes)
without being killed, the outcome of which may be loss
in vivo of the endothelial cell covering of vessels and
compromise of the permeability barrier [7,81.
Additional evidence suggesting that endothelial cells
from different vascular beds vary significantly with re-
spect to the mechanism of neutrophil-mediated injury
comes from some recent in vivo observations in rats.
Immune complex deposition (involving rabbit polycional
IgG antibody to bovine serum albumin) has been induced
in the lungs and dermis by the local injection (into air-
ways or dermis) of antibody and the systemic injection of
antigen. Immune complex deposition occurs in alveolar
walls of lung and in venules and capillaries of the der-
mis, leading to complement-dependent and neutrophil-
dependent vascular injury, which results in endothelial
cell damage, increased vascular permeability, and hem-
orrhage. Vascular injury in the lung is significantly di-
minished if catalase is intermixed with the antibody or if
the animals are systemically treated with the iron chela-
tor deferroxamine [9]. In striking contrast, no protection
from injury is obtained in the dermis under the same
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conditions of treatment, even when catalase is covalently
linked to the IgG [9]. This striking discordance in effects
of interventions (catalase and deferroxamine) strongly
suggests that, whereas endothelial cells in both the lung
and the dermis are damaged by products of activated
neutrophils, toxic oxygen products are vital for damage
of lung microvascular endothelial cells and irrelevant to
damage of dermal vascular endothelial cells. Very little
is known regarding the mechanism by which dermal vas-
cular endothelial cells are damaged by products of acti-
vated neutrophils. More definitive studies will probably
require access to primary cultures of microvascular en-
dothelial cells from each of the two organs, but to date
we have not been successful in culturing dermal mi-
crovascuiar endothelial cells in sufficient quantities to
carry out the necessary studies.
PARTICIPATION OF ENDOTHELIAL CELLS IN
THEIR KILLING BY NEUTROPHILS
As strange as it may seem, there is now incontrovert-
ible evidence that, in the interaction of phorbol ester-
stimulated neutrophils and endothelial cells, the latter
play an active role in events leading to their own damage
and/or destruction. Collectively, the participation of en-
dothelial cells in their demise by activated neutrophils
can be considered an “autotoxic” response of endothe-
hal cells. There are two bodies of evidence that support
this conclusion. The first relates to the killing of rat
pulmonary artery endothelial cells by human neutrophils.
It has been shown that this killing requires oxygen prod-
ucts of the neutrophil [ 1-4] . On the basis of the protec-
tive effects of catalase, deferroxamine, and H0 scaven-
gers such as dimethyl thiourea and dimethyl sulfoxide, it
seems likely that HO may be the key reactive species of
oxygen responsible for the killing process. Inasmuch as
it has been demonstrated that phorbol-activated human
neutrophils generate O2 and H202 but not HO- unless
iron is added to the extracellular fluid [10], the observa-
tion related to the iron requirement for neutrophil killing
of endothelial cells implies that iron is available either
from the extracellular fluid or from the endothelial cell
itself. Accordingly, rat pulmonary artery endothelial
cells have been pretreated with deferroxamine and
washed and then neutrophils have been added. Their
ability to kill the endothelial cells was assessed after
addition of phorbol ester. The results were striking: Pre-
treatment of endothelial cells with deferroxamine led to
almost 70% reduction in their killing by activated neu-
trophils [1 1]. It could be demonstrated by high-perfor-
mance liquid chromatography that extracts of the defer-
roxamine-treated cells contained deferroxamine that was
bound to iron (Fe3  ) The location within the endothelial
cell of the iron-deferroxamine complex (which might
provide vital information related to where in the endo-
thelial cell engagement of iron in a manner that leads to
damage occurs) is not known; this finding demonstrates
that the deferroxamine has intercepted iron within the
endothelial cell and that this iron is related to the cyto-
toxic events. On the basis of this information, it can be
concluded that neutrophil-mediated killing of endothelial
cells requires the engagement of iron from the target cell.
The presumption is that iron is released and converted by
O2 to its transition state (Fe2  ) which permits it to
react with H2O2 to generate H0
A second line of evidence for autotoxic responses of
endothelial cells comes from recent observations that rat
pulmonary artery endothelial cells contain xanthine de-
hydrogenase (xd) and xanthine oxidase (xo) in a ratio of
approximately 2: 1 . If endothelial cells are pretreated
with inhibitors of xo, namely, allopurinol and oxypuri-
nol, and then washed, the ability of phorbol ester-acti-
vated neutrophils to kill these cells is greatly attenuated,
in proportion to the concentration of inhibitor employed
[1 2] . In parallel experiments, pretreatment of neutrophils
does not attenuate their ability to kill endothelial cells,
indicating that the effect of allopurinol and oxypurinol is
related to their interaction with the endothelial cell. Al-
though allopurinol might be functioning as a scavenger
of HO , it seems unlikely that this explains the protective
effects of the inhibitor, since the scavenging ability of
allopurinol requires millimolar concentrations. A more
plausible explanation is that these compounds inhibit xd
and/or xo in the treated endothelial cells, a finding that
has been confirmed by direct measurements of xd and xo
in the treated endothelial cells. These observations imply
that availability of xd and/or xo in endothelial cells is
linked to destruction of these cells by activated neutro-
phils. Perhaps relevant to these findings is the fact that,
when phorbol ester-stimulated neutrophils interact with
endothelial cells, there is a fairly rapid conversion of xd
to xo (with an inversion of xd/xo the ratio from 2: 1 to
1 :2), with the conversion being irreversible (not revers-
ible by the addition of reducing agents). The addition of
catalase, superoxide dismutase (SOD), or deferroxamine
fails to prevent conversion of xd to xo in the endothelial
cells following activation of neutrophils. Also, CGD
cells are fully effective in causing conversion of xd to xo,
providing compelling evidence that the conversion pro-
cess is not related to an oxygen products of the neutrophil
[12] . Although it can be speculated that the neutrophil-
derived “converting factor” may be a granule secretion
product, this is not proven at present.
On the basis of these data, it seems possible that neu-
trophil interaction with endothelial cells results in addi-
tional xo activity, which will provide for more genera-
tion of 02 within the endothelial cell, adding to the
oxygen radical burden of the cell. A more comprehen-
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sive analysis of how this fits into the scheme of events
leading to injury or death of endothelial cells is presented
below.
BIOCHEMICAL EVENTS RELATED TO INJURY OF
ENDOTHELIAL CELLS
There is no consensus regarding the biochemical
events that can be linked to damage or killing of endo-
thelial cells by toxic oxygen products from activated neu-
trophils or by the addition of reagent H202. As referred
to above, rat pulmonary artery endothelial cells are killed
over a period of several hours following exposure to
phorbol ester-activated human neutrophils, using effec-
tor/target cell ratios as small as 2:1 [4,1 1 ,12]. Since neu-
trophils from patients with COD fail to induce killing,
the process of cell injury is linked to oxygen products of
the respiratory burst. Furthermore, catalase but not SOD
is protective, as are the H0 scavengers such as DMSO
and DMTU. Although it is possible that the cell killing
process could be related to the formation of iron radicals
(ferryl and/or perferryl ions), the role of HO- also seems
likely. The killing of endothelial cells by H2O2 follows a
similar pattern of protective interventions, indicating that
extrinsic O2 is not essential for the cytolytic pathway.
The evidence (referred to above) that inhibitors of endo-
thelial cell xo (and xd) will block a significant amount of
neutrophil-mediated killing suggests that intracellular
formation of O2 within the endothelial ccii is somehow
linked to the cell killing process. We speculate that in-
tracellular formation of O2 (whether by xo, cyclooxy-
genase, mitochondrial enzymes, or some other source)
brings about release of Fe3  from its storage form in
ferritin and formation of Fe2  which can then interact
with H2O2 (which has diffused into the endothelial cell
after its formation on the cell membrane of the neutro-
phil), following which H,O2 is reduced to H0 and Fe2
is recycled to Fe3  . The influx of H2O2 into the endo-
thelial cell would also be expected to result in a fall in
intracellular levels of ATP, because of both impaired
synthesis and accelerated breakdown [ 1 3 -2 1 1. Even af-
ter the fail in ATP, a rise in intracellular calcium due to
influx from the extracellular compartment would be cx-
pected [22-28].
It is not at all clear what biochemical events can be
directly linked to cell injury. Although it is known that
H2O2 and other oxygen products (including hypochior-
ous acid (HOd), a halide metabolite resulting from the
action of myeloperoxidase on H2O2) can react with sur-
face molecules on cell membranes [29], to what extent
these effects are relevant to cytotoxicity is not known. It
is known that H2O, can inactivate glyceraldehyde-
3-phosphate dehydrogenase [2 1] and also bring about
activation of ADP-ribose polymerase [14], the result of
which can cause a fall in intracellular levels of NAD.
Whether these findings can be generalized to include
mechanisms of cytotoxicity in endothelial cells is not
known. We have not been able to demonstrate that the
inhibitor of ADP-ribose polymerase, namely. 3-
aminobenzidine, will protect endothelial cells from
H2O2-mediated damage (Varani , J . , and Ward , P. A.,
unpublished data). Furthermore, the observation that red
blood cell killing by oxygen products of neutrophils in-
volves a role for O2 [30] and the fact that red blood
cells lack ADP-ribose polymerase suggests the likeli-
hood of multiple explanations for biochemical events re-
lated to neutrophil or H,O2-mediated killing of endothe-
hal cells.
ENDOTHELIAL KILLING: SYNERGY BETWEEN
PROTEASES AND H2O2
Recent evidence indicates that endothelial cells (from
the rat pulmonary artery) are killed following addition of
H2O2 in a time-dependent process. The endpoint, which
is release of 51Cr, is ordinarily established at 4 hr for
convenience, even though the release of 5tCr continues
for a total period of 8 hr, following which there is plateau
in the release of 51Cr. During the first 4 hr, the addition
of protease inhibitors such as soybean trypsin inhibitor
(SBTI) does not reduce the release of 5tCr. However,
when the endpoint of I 8 hr is used, the continued pres-
ence of catalase ( 180 units/mi) alone produced 10% ±
1% protection, the continued presence of SBTI produced
35% ± 4% protection whereas the combination of cata-
lase and SBTI yielded 78% ± 5% protection, implying
that over this extended period there may be synergistic
effects of H,02 and proteases, the result of which is
intensified cell injury 1311. The experiments were then
extended to employ addition of porcine pancreatic
elastase (2.3 units/mi), which at 18 hr caused 13% ± I %
release of 51Cr, H,O, ( 100 nmol), which in the same
period of time caused 33% ± 1% release of 51Cr, or the
combination of elastase and H2O,, the result of which
was 75% ± 2% release of51Cr. Similarresults have been
obtained with the use oftrypsin and chymotrypsin. These
data show beyond reasonable question that, under the
experimental conditions employed, proteases and H20,
act in synergistic manner to bring about cytotoxic events
(defined by 51Cr release) in the endothelial cell. There is
at present no explanation for how this occurs, why a
prolonged duration of contact of these substances with
the endothelial cell is required, and whether the 51Cr
release at 4 hr vs. 18 hr involves different mechanisms of
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EFFECTS OF CYTOKINES ON NEUTROPHIL
MEDIATED KILLING OF ENDOTHELIAL CELLS
Cytokines have a plethora of biological effects on a
variety of different cells. With regard to phagocytic
cells, tumor necrosis factor-a (TNFa) and interleukin- 1 3
(IL- 1 3) can ‘ ‘prime’ ‘ these cells for exaggerated oxygen
radical responses [32-34]. At much higher concentra-
tions, direct stimulation of neutrophils and macrophages
by cytokines occurs. The ability of these cytokines to
alter endothelial cells in a manner that leads to increased
adhesive interactions with neutrophils is a well-known
phenomenon [35-37]. This is a slowly developing pro-
cess of up-regulation in the endothelial cell, requires sev-
eral hours, and depends on protein synthesis, probably
involving increased expression on the endothelial cell of
at least two different adhesion-promoting molecules. The
complementary adhesion-reactive molecule on the neu-
trophil involves the CR3 (complement receptor) moiety
and probably, to a lesser extent, at least one other adhe-
sion-related molecule. Not only does prior exposure of
endothelial cells to TNFa or IL- 1 3 lead to augmented
adhesive interactions with neutrophils, this also results in
a greatly enhanced (two- to threefold) cytotoxic outcome
in the presence of phorbol ester activated neutrophils
[38]. Whether the increased killing ofendothelial cells is
a reflection solely of enhanced adhesive interactions with
neutrophils or whether other mechanisms are also re-
sponsible for the enhanced cytotoxicity is not currently
known. It should be noted that the ability of TNF to
cause rapid conversion of xd to xo in endothelial cells
may be another event that puts these cells at added risk of
injury [39]. By whatever mechanism the enhanced cyto-
toxicity occurs, these observations may be relevant to
clinical studies featuring the infusion of TNF into hu-
mans, in which case evidence for serious acute injury of
the pulmonary microvasculature has been obtained.
Another finding of relevance to these issues comes
from recent observations that, whereas exposure of hu-
man umbilical vein endothelial cells to TNF does not
itself result in evidence of cell injury when the cells are
examined immediately after exposure, if endothelial
cells exposed for I 8 hr to as little as 2 ng TNFa/ml are
then washed and placed in a simple culture medium
(Hanks balanced salt solution), there is progressive cvi-
dence of cell injury over the next 4 hr. as reflected by
51Cr release [40]. The cytotoxic effects are abrogated if
the TNFa used for the 18 hr treatment regimen is either
heat-inactivated or blocked by the addition of specific
antibody. lL-l3 has similar effects, whereas M-CSF is
without any effect on the endothelial cells. Furthermore,
endothelial cells show a degree of specificity for the
effects of TNFa inasmuch as neither human dermal fi-
broblasts nor squamous epithelial cells from skin develop
evidence of cytotoxic effects after exposure to TNFa.
Although the manner by which TNFa causes suscepti-
bility of endothelial cells to toxic effects under these
special conditions is unknown, the fact the deferroxam-
inc is protective suggests that an iron-dependent pathway
of toxicity is involved. Not surprising, allopurinol is not
protective, in accordance with the fact that human um-
bilical vein endothelial cells are largely devoid of detect-
able xd and xo. However, the ability of several cycloox-
ygenase inhibitors (ibuprofen, indomethacin, piroxicam)
to protect against the toxicity following exposure of en-
dothelial cells to TNFa may imply that generation of
O2 from cyclooxygenase is relevant to the mechanism
of injury. These data indicate that exposure of endothe-
hal cells to TNFa and IL-13 alters these cells in a man-
ncr that makes them significantly susceptible to injury,
by either direct or indirect (neutrophil-mediated) path-
ways.
CONCLUSIONS
As is evident from this information, endothelial cells
have very complex biological responses that have impor-
tant implications for the outcome of the inflammatory
response. The recognition that the susceptibility of en-
dothelial cells to injury may vary considerably, depend-
ing on the species of origin or the source of the microvas-
cular bed from which the cells originate, has important
implications suggesting that there is a significant diver-
sity in behavior of endothelial cells. The increasing rec-
ognition that the events related to how endothelial cells
are injured by products of activated neutrophils are com-
plex and involve factors originating both in the effector
cells (neutrophils) as well as in the target (endothelial)
cells adds a new dimension and suggests that a variety of
different therapeutic interventions may be employed for
the protection of endothelial cells during the inflamma-
tory response. Finally, the increasing knowledge that
endothelial cells can respond directly to inflammatory
mediators suggests that a more detailed analysis of sig-
nal-transduction events in these cells should provide
some important clues to their biology.
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